WebDec 21, 2024 · CytRx’s most recent advanced drug conjugate, aldoxorubicin, is an improved version of the widely used anti-cancer drug doxorubicin and has been out-licensed to ImmunityBio, Inc. In addition, CytRx’s drug candidate, arimoclomol, was sold to Orphazyme A/S in exchange for milestone payments and royalties. Orphazyme is developing … WebJul 13, 2024 · CytRx Corporation (OTCQB: CYTR) CytRx Corporation Enters Into Securities Purchase Agreement for $10 Million With Healthcare-Focused Institutional Investor July 13, 2024 08:00 AM Eastern Daylight Time
CytRx Highlights ImmunityBio
http://archive.wn.com/2013/10/02/1400/netherlandspost/ WebApr 25, 2024 · Howard Fine. April 25, 2024. 1027. Fifteen years ago, Brentwood-based biopharma company CytRx Corp. was flying high, with its share price topping $150 as investors poured money into its efforts to ... chipr loft
Cyxtera Technologies Inc. - MarketWatch
WebApr 1, 2024 · CYTRX CORPORATION. Cytrx Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation F.. CYTRX CORP Management's Discussion and Analysis of Financial Condition and Results of .. Cytrx : Announces Distribution of Series D Preferred Stock to Holders of its Common Stock .. WebMar 10, 2024 · Headline. LadRx Corporation Issues Corporate Update for 3Q22. finance.yahoo.com - November 27 at 9:41 AM. LadRx Corporation Announces OTCQB Ticker Change to LADX - Business Wire. businesswire.com - October 5 at 11:30 PM. CytRx Corporation Relaunches as LadRx Corporation - Business Wire. businesswire.com - … WebJan 11, 2016 · CytRx is also expanding its pipeline of oncology candidates at its laboratory facilities in Freiburg, Germany, through its LADR™ (Linker Activated Drug Release) technology platform, a discovery ... grapevine best steakhouse